143 related articles for article (PubMed ID: 11526904)
21. Thailand's Prime-Boost HIV Vaccine Phase III.
Trinvuthipong C
Science; 2004 Feb; 303(5660):954-5. PubMed ID: 14963308
[No Abstract] [Full Text] [Related]
22. AIDSVAX is safe, but efficacy question remains. VaxGen founder discusses quest for AIDS vaccine.
Francis DP
AIDS Alert; 2001 Nov; 16(11):141-2, 147. PubMed ID: 11692665
[No Abstract] [Full Text] [Related]
23. AIDS research. Debate begins over new vaccine trials.
Cohen J
Science; 2001 Sep; 293(5537):1973. PubMed ID: 11557856
[No Abstract] [Full Text] [Related]
24. VaxGen releases interim results of the clinical trial of its experimental vaccine.
Can HIV AIDS Policy Law Rev; 2002 Mar; 6(3):48-9. PubMed ID: 14979258
[No Abstract] [Full Text] [Related]
25. Results in for first phase III vaccine trial.
AIDS Patient Care STDS; 2003 Nov; 17(11):607-8. PubMed ID: 14750221
[No Abstract] [Full Text] [Related]
26. HIV-vaccine research and development in Thailand: evolution and challenges.
Pitisuttithum P; Choopanya K; Rerk-Ngnam S
Vaccine; 2010 May; 28 Suppl 2():B45-9. PubMed ID: 20510743
[TBL] [Abstract][Full Text] [Related]
27. [The quest for an HIV vaccine].
Girard MP
Bull Acad Natl Med; 2005 May; 189(5):831-44; discussion 844. PubMed ID: 16433455
[TBL] [Abstract][Full Text] [Related]
28. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.
Pitisuttithum P; Gilbert P; Gurwith M; Heyward W; Martin M; van Griensven F; Hu D; Tappero JW; Choopanya K;
J Infect Dis; 2006 Dec; 194(12):1661-71. PubMed ID: 17109337
[TBL] [Abstract][Full Text] [Related]
29. An HIV vaccine: how and when?
Esparza J
Bull World Health Organ; 2001; 79(12):1133-7. PubMed ID: 11799445
[TBL] [Abstract][Full Text] [Related]
30. Impending AIDS vaccine trial opens old wounds.
Balter M
Science; 1998 Jan; 279(5351):650. PubMed ID: 9471726
[No Abstract] [Full Text] [Related]
31. HIV vaccine research in Thailand: lessons learned.
Pitisuttithum P
Expert Rev Vaccines; 2008 Apr; 7(3):311-7. PubMed ID: 18393601
[TBL] [Abstract][Full Text] [Related]
32. Public health. AIDS vaccine still alive as booster after second failure in Thailand.
Cohen J
Science; 2003 Nov; 302(5649):1309-10. PubMed ID: 14631004
[No Abstract] [Full Text] [Related]
33. Large-scale HIV vaccine trial to begin this summer.
Highleyman L
BETA; 1998 Jul; ():3. PubMed ID: 11365557
[TBL] [Abstract][Full Text] [Related]
34. Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand.
Karnasuta C; Paris RM; Cox JH; Nitayaphan S; Pitisuttithum P; Thongcharoen P; Brown AE; Gurunathan S; Tartaglia J; Heyward WL; McNeil JG; Birx DL; de Souza MS;
Vaccine; 2005 Mar; 23(19):2522-9. PubMed ID: 15752839
[TBL] [Abstract][Full Text] [Related]
35. Eager Thailand takes on questionable therapies.
Birmingham K
Nat Med; 2002 Aug; 8(8):767-8. PubMed ID: 12152015
[No Abstract] [Full Text] [Related]
36. [HIV/AIDS vaccines: heading for new vaccine approaches?].
Girard MP
Bull Soc Pathol Exot; 2008 Jun; 101(3):220-6. PubMed ID: 18681215
[TBL] [Abstract][Full Text] [Related]
37. HIV vaccine: sell-out or vote of confidence by Genentech?
Wadman M
Nature; 1996 Feb; 379(6568):757. PubMed ID: 8587588
[No Abstract] [Full Text] [Related]
38. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
Emini EA; Koff WC
Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
[No Abstract] [Full Text] [Related]
39. VaxGen AIDS vaccine clears phase III safety hurdle again.
AIDS Read; 2001 May; 11(5):246. PubMed ID: 11392687
[No Abstract] [Full Text] [Related]
40. Social and behavioral issues in phase III HIV preventive vaccine trials.
Grinstead OA
AIDS; 1995; 9 Suppl A():S245-50. PubMed ID: 8819592
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
